Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
about
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer
description
article publié dans Nature Communications
@fr
im November 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Nature Communications
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer
@en
Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer
@nl
type
label
Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer
@en
Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer
@nl
prefLabel
Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer
@en
Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer
@nl
P2093
P2860
P50
P1476
Targeting 17q23 amplicon to ov ...... therapy in HER2+ breast cancer
@en
P2093
Cheng Huang
Hanchen Xu
Haniyeh Eyvani
Hyun Ho Choi
Jiangsheng Xu
Lifei Wang
Michael Frieden
P2860
P2888
P356
10.1038/S41467-018-07264-0
P407
P577
2018-11-09T00:00:00Z